Recovery of dopamine transporter binding and function after intrastriatal administration of the irreversible inhibitor RTI-76 {3β-(3p-chlorophenyl)tropan-2β-carboxylic acid p-isothiocyanatophenylethyl ester hydrochloride}

Journal of Pharmacology and Experimental Therapeutics

Volumn 279, Issue 1, 1996, Pages 200-206

  Fleckenstein, Annette E ^a,e   Pögün, Sakire ^b   Carroll, F Ivy ^c   Kuhar, Michael J ^d  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b EGE UNIVERSITY   (Turkey)

^c RTI INTERNATIONAL   (United States)

^d EMORY UNIVERSITY   (United States)

^e UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3BETA (4 CHLOROPHENYL)TROPAN 2BETA CARBOXYLIC ACID 4 ISOTHIOCYANATOPHENETHYL ESTER; 3BETA (4 FLUOROPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; 3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; COCAINE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE TRANSPORTER; DOPAMINE UPTAKE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DISSOCIATION CONSTANT; DOPAMINE UPTAKE; DOSE RESPONSE; DRUG RECEPTOR BINDING; INTRACEREBRAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPTOSOME;

ANIMALS; CARRIER PROTEINS; COCAINE; CORPUS STRIATUM; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; TROPANES;

EID: 0030434485     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. BANNON, M. J., POOSCH, M. S., XIA, Y., GOEBEL, D. J., CASSIN, B. AND KAPATOS, G.: Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age. Proc. Natl. Acad, Sci. U.S.A. 89: 7095-7099, 1992.
2. BATTAGLIA, G., NORMAN, A. B. AND CREESE, I.: Age-related differential recovery rates of rat striatal D-1 dopamine receptors following irreversible inactivation. Eur. J. Pharmacol. 145: 281-290, 1988.
3. BERGMAN, J., MADRAS, B. K., JOHNSON, S. E. AND SPEALMAN, R. D.: Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys. J. Pharmacol. Exp. Ther. 251: 150-155, 1989.
4. BOJA, J. W., ABDUR RAHMAN, M., PHILIP, A., LEWIN, A. H., CARROLL, F. I. AND KUHAR, M. J.: Isothiocyanate derivatives of cocaine: Irreversible inhibition of ligand binding at the dopamine transporter. Mol. Pharmacol. 39: 339-345, 1990.
5. 125I]RTI-55 to dopamine and serotonin transporters in rat brain. Synapse 12: 27-36, 1992.
6. 3H]cocaine in striatum and its relationship to the dopamine transporter. Membr. Biochem. 7: 87-106, 1988.
7. CARROLL, F. I., GAO, Y., ABRAHAM, P., LEWIN, A. H., LEW, R., PATEL, A., BOJA, J. W. AND KUHAR, M. J.: Probes for the cocaine receptor. Potentially irreversible ligands for the dopamine transporter. J. Med. Chem. 35: 1813-1817, 1992.
8. 3H]mazindol. Neuroscience 49: 317-327, 1992.
9. GU, H., WALL, S. C. AND RUDNICK, G.: Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics and ion dependence. J. Biol. Chem. 269: 7124-7130, 1994.
10. 1 dopamine receptors in rat striatum. Eur. J. Pharmacol. 121: 31-38, 1986.
11. IZENWASSER, S., ROSENBERGER, J. G. AND COX, B. M.: The cocaine analog WIN 35,428 binds to two sites in fresh rat caudate-putamen: Significance of assay procedures. Life Sci. 52: PL141-PL145, 1993.
12. KIRIFIDES, A. L., HARVEY, J. A. AND ALOYO, V. J.: The low affinity binding site for the cocaine analog, WIN 35,428 is an artifact of freezing caudate tissue. Life Sci. 50: PL139-PL142, 1992.
13. MADRAS, B. K., FAHEY, M. A., BERGMAN, J., CANFIELD, D. R. AND SPEALMAN, R. D.: Effects of cocaine and related drugs in nonhuman primates. I. [3H]Cocaine binding sites in caudate-putamen. J. Pharmacol. Exp. Ther. 251: 131-141, 1989.
14. MARTEL, J.-C., CERRUTI, C., FLECKENSTEIN, A., CARROLL, F. I., KUHAR, M. J. AND PATEL, A. P.: Turnover of rat dopamine transporter protein in rDAT-LLC-PK1 cells: Use of an irreversible ligand (RTI-76) and antisense oligonucleotides. Soc. Neurosci. Abst. 21: 376, 1995.
15. MAUGER, J.-P., SLADECZEK, F. AND BOCKAERT, J.: Characteristics and metabolism of α1 adrenergic receptors in a nonfusing muscle cell line. J. Biol. Chem. 257: 875-879, 1982.
16. MCPHERSON, G. A. EBDA-Ligand-Kinetic-Lowry, Elsevier-Biosoft, Cambridge, 1986.
17. MUNSON, P. J. AND RODBARD D.: Ligand: A versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 107: 220-239, 1980.
18. NICKERSON, M.: Nonequilibrium drug antagonism. Pharmacol. Rev. 9: 246-259, 1957.
19. NIZNIK, H. B., FOGEL, E. F., FASSOS, F. F. AND SEEMAN, P.: The dopamine transporter is absent in Parkinsonian putamen and reduced in the caudate nucleus. J. Neurochem. 56: 192-198, 1991.
20. 2 dopamine receptors as a function of aging and chronic reserpine treatment following irreversible modification: A key to receptor regulatory mechanisms. J. Neurosci. 7: 1484-1491, 1987.
21. PATEL, A. P., CERRUTI, C., VAUGHAN, R. AND KUHAR, M. J.: Developmentally regulated glycosylation of a dopamine transporter. Dev. Brain Res. 83: 53-58, 1994.
22. PATEL, A. P., MARTEL, J.-C., VANDENBERGH, D. J., UHL, G. R. AND KUHAR, M. J.: Cell lines expressing human and rat dopamine transporter cDNAs: Different ligands yield different radiolabeling patterns. Soc. Neurosci. Abst. 21: 781, 1995.
23. PATEL, A. P., UHL, G. AND KUHAR, M. J.: Species differences in dopamine transporters: Postmortem changes and glycosylation differences. J. Neurochem. 61: 496-500, 1993.
24. PILOTTE, N. S., SHARPE, L. J. AND KUHAR, M. J.: Withdrawal of repeated intravenous infusions of cocaine persistently reduces binding to dopamine transporters in the nucleus accumbens of Lewis rats. J. Pharmacol. Exp. Ther. 269: 963-969, 1994.
25. 3H]WIN 35,428 binding to the dopamine uptake carrier. II. Effect of membrane fractionation procedure and freezing. J. Neurosci. Methods 51: 31-38, 1994.
26. REITH, M. E. A. AND SELMECI, G.: Radiolabeling of dopamine uptake sites in mouse striatum: Comparison of binding sites for cocaine, mazindol, and GBR 12935. Naunyn-Schmiedeberg's Arch. Pharmacol. 345: 309-318, 1992.
27. REVAY, R., VAUGHAN, R., GRANT, S. AND KUHAR, M. J.: Dopamine transporter immunohistochemistry in median eminence, amygdala and other areas of the rat brain. Synapse 22: 93-99, 1996.
28. RITZ, M. C., LAMB, R. J., GOLDBERG, S. R. AND KUHAR, M. J.: Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science (Wash. DC) 237: 1219-1223, 1987.
29. 3H]cocaine binding associated with dopamine uptake sites in the rat striatum and human putamen decrease after dopaminergic denervation and in Parkinsons disease. Naunyn-Schmiedeberg's Arch. Pharmacol. 329: 227-235, 1985.
30. 3H]threo-(±)-methylphenidate binding to rat striatal tissue. J. Neurochem. 48: 102-105, 1987.
31. SEEMAN, P. AND NIZNIK, H. B.: Dopamine receptors and transporters in Parkinson's disease and schizophrenia. Fed. Am. Soc. Exp. Biol. 4: 2737-2744, 1990.
32. 3H]mazindol-labeling of dopamine transporter in rat nucleus accumbens. Eur. J. Pharmacol. 203: 141-144, 1991.
33. SILVIA, C. P., JABER, M., KING, G. R., CALVI, C., ELLINWOOD, E. H. AND CARON, M. G.: Antisense oligodeoxynucleotides to the dopamine transporter differentiate the effects of cocaine and amphetamine. FASEB J Vol. 9, A402, 1995.
34. 1-adrenergic receptors in rat submaxillary glands. Mol. Pharmacol. 23: 282-288, 1983.
35. 3H-TCP binding and synaptosomal dopamine uptake by metaphit, a proposed PCP receptor acylator. Life Sci. 41: 2645-2654, 1987.
36. 3H-GBR 12,935 are differentially regulated by chronic cocaine self-administration. J. Neurosci. 14: 2966-2979, 1994.
37. 2 dopamine receptors in brain. J. Pharmacol. Exp. Ther. 257: 608-615, 1991.
38. ZELNIK, N., ANGEL, I., PAUL, S. M. AND KLEINKAN, J. E.: Decreased density of human striatal dopamine uptake sites with age. Eur. J. Pharmacol. 126: 175-176, 1986.
39. ZIMANYI, I., JACOBSON, A. E., RICE, K. C., LAJTHA, A. AND REITH, M. E. A.: Long-term blockade of the dopamine uptake complex by metaphit, an isothiocyanate derivative of phencyclidine. Synapse 3: 239-245, 1989.